• Yatsen presented a record 20 research studies at the 36th IFSCC Congress in Perth, nearly double its 2025 total.
• The congress marked its fifth consecutive appearance; its studies were selected from more than 1,200 submissions.
• A new microbiology testing method presented at the event minimizes preservative interference to reduce false negatives.
• Cumulative R&D investment exceeded RMB 770 million, with annual spending above 3% of revenue for four consecutive years.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Yatsen Holding Ltd. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202610150146PR_NEWS_EURO_ND__EN73096) on October 15, 2026, and is solely responsible for the information contained therein.